December 21, 2021
2 min watch
Save
VIDEO: More cancers being targeted with CAR T-cells
In this video, Rayne Rouce, MD, discusses the top chimeric antigen receptor T-cell therapy-related presentations at ASH, including several presentations targeting T-cell malignancies, which she said is exciting.
"We are seeing more and more cancers being targeted with CAR T-cells," Rouce, pediatric oncologist and physician scientist at Texas Children's Hospital in the Center for Cell and Gene Therapy at Baylor College of Medicine in Houston, Tex., said.
"CAR T-cells have been exciting in hematologic malignancies for a while, but really we have lagged when it comes to targeting other leukemias, lymphomas and myelomas,” she said.
Published by:
Sources/Disclosures
Collapse
Source:
Disclosures:
Rouce reports consulting for Pfizer, receiving research funding from Tessa Therapeutics, and advisory board honoraria from Novartis.